- Published on
Emergency and Acute Medicine – Otitis Media
Otitis media is an inflammatory condition of the middle ear and is one of the most common infections encountered in early childhood, particularly between 6 and 36 months of age. It is characterized by a rapid onset of local and systemic symptoms and has a high recurrence rate, with more than one-third of children experiencing more than five episodes by the age of seven. Although it predominantly affects children, otitis media can also occur in adults.
The condition most often develops in association with upper respiratory tract infections, which lead to eustachian tube dysfunction and impaired drainage of the middle ear. Viral pathogens commonly implicated include parainfluenza virus, respiratory syncytial virus, influenza virus, adenovirus, and rhinovirus. Bacterial causes include Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, Streptococcus pyogenes, and Mycoplasma pneumoniae. Predisposing factors include impaired mucociliary function, immunodeficiency, nasotracheal intubation, and certain populations such as American Indians, Eskimos, and individuals with Down syndrome, cleft palate, diabetes, vitamin A deficiency, or HIV. Additional risk factors include daycare attendance, family history, exposure to parental smoking, pacifier use, and bottle-feeding.
Diagnosis is primarily clinical and follows the American Academy of Pediatrics 2013 guidelines. Otitis media should be diagnosed when there is moderate to severe bulging of the tympanic membrane, mild bulging of the tympanic membrane accompanied by recent onset of ear pain, or new otorrhea not attributable to otitis externa. The diagnosis should not be made in the absence of middle ear effusion, which is best assessed using pneumatic otoscopy or tympanometry. Recurrent otitis media is defined as three episodes within six months or four episodes within one year, with at least one episode occurring in the preceding six months.
Patients typically present with ear pain, irritability, fever, and symptoms of an upper respiratory infection such as rhinorrhea. Younger children may exhibit poor feeding, vomiting, diarrhea, or tugging at the ear, while older children and adults may complain of a plugged-ear sensation, vertigo, tinnitus, or conjunctivitis. On physical examination, the tympanic membrane often appears erythematous, inflamed, and bulging, with decreased mobility and obscured landmarks. New-onset otorrhea in the absence of otitis externa is also a key finding.
The essential evaluation includes careful otoscopic examination with full visualization of the tympanic membrane and assessment of its mobility. Laboratory testing is generally unnecessary, and cultures are not helpful unless obtained via tympanocentesis. Imaging, such as computed tomography, is reserved for suspected complications like mastoiditis. Tympanocentesis may be indicated in cases of severe pain or toxicity, failure of antimicrobial therapy, suspected suppurative complications, illness in neonates, or immunocompromised patients.
Management depends on age, severity, and laterality of infection. Many mild cases resolve spontaneously without antibiotics. Antibiotic therapy is recommended for all infants younger than six months, children younger than two years with bilateral otitis media, children older than six months with severe symptoms (persistent otalgia for more than 48 hours or fever ≥102.2°F), and cases with tympanic membrane rupture and drainage. In otherwise healthy children aged six months or older with mild symptoms or uncertain diagnosis, a period of observation with close follow-up in two to three days is appropriate, provided caregivers are reliable. Antipyretics and analgesics are essential for symptom control, while antihistamines, decongestants, and steroids have not shown proven benefit.
First-line antibiotic therapy typically includes high-dose amoxicillin, with amoxicillin–clavulanate or alternative agents such as azithromycin or cefuroxime used based on allergy history, recent antibiotic use, or local resistance patterns. Parenteral antibiotics are reserved for toxic-appearing infants, immunocompromised patients, or those unable to tolerate oral therapy.
Most patients can be safely discharged with appropriate treatment and follow-up. Admission is indicated for febrile or toxic children younger than one year, immunocompromised patients, those with significant dehydration, inability to tolerate oral intake, suspected serious associated infection, unreliable caregivers, or concern for abuse. Follow-up is recommended within 10–14 days to ensure resolution, with earlier reassessment if symptoms fail to improve within 24–48 hours or worsen.
Important complications of otitis media include recurrent infections, tympanic membrane perforation, serous otitis media, hearing loss, facial nerve injury, mastoiditis, cholesteatoma, meningitis, and other intracranial infections. A key clinical pearl is that in otherwise healthy children aged six months or older with mild symptoms, observation without immediate antibiotics and close follow-up is often a safe and effective approach.
Otitis media is an inflammatory condition of the middle ear and is one of the most common infections encountered in early childhood, particularly between 6 and 36 months of age. It is characterized by a rapid onset of local and systemic symptoms and has a high recurrence rate, with more than one-third of children experiencing more than five episodes by the age of seven. Although it predominantly affects children, otitis media can also occur in adults.
The condition most often develops in association with upper respiratory tract infections, which lead to eustachian tube dysfunction and impaired drainage of the middle ear. Viral pathogens commonly implicated include parainfluenza virus, respiratory syncytial virus, influenza virus, adenovirus, and rhinovirus. Bacterial causes include Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, Streptococcus pyogenes, and Mycoplasma pneumoniae. Predisposing factors include impaired mucociliary function, immunodeficiency, nasotracheal intubation, and certain populations such as American Indians, Eskimos, and individuals with Down syndrome, cleft palate, diabetes, vitamin A deficiency, or HIV. Additional risk factors include daycare attendance, family history, exposure to parental smoking, pacifier use, and bottle-feeding.
Diagnosis is primarily clinical and follows the American Academy of Pediatrics 2013 guidelines. Otitis media should be diagnosed when there is moderate to severe bulging of the tympanic membrane, mild bulging of the tympanic membrane accompanied by recent onset of ear pain, or new otorrhea not attributable to otitis externa. The diagnosis should not be made in the absence of middle ear effusion, which is best assessed using pneumatic otoscopy or tympanometry. Recurrent otitis media is defined as three episodes within six months or four episodes within one year, with at least one episode occurring in the preceding six months.
Patients typically present with ear pain, irritability, fever, and symptoms of an upper respiratory infection such as rhinorrhea. Younger children may exhibit poor feeding, vomiting, diarrhea, or tugging at the ear, while older children and adults may complain of a plugged-ear sensation, vertigo, tinnitus, or conjunctivitis. On physical examination, the tympanic membrane often appears erythematous, inflamed, and bulging, with decreased mobility and obscured landmarks. New-onset otorrhea in the absence of otitis externa is also a key finding.
The essential evaluation includes careful otoscopic examination with full visualization of the tympanic membrane and assessment of its mobility. Laboratory testing is generally unnecessary, and cultures are not helpful unless obtained via tympanocentesis. Imaging, such as computed tomography, is reserved for suspected complications like mastoiditis. Tympanocentesis may be indicated in cases of severe pain or toxicity, failure of antimicrobial therapy, suspected suppurative complications, illness in neonates, or immunocompromised patients.
Management depends on age, severity, and laterality of infection. Many mild cases resolve spontaneously without antibiotics. Antibiotic therapy is recommended for all infants younger than six months, children younger than two years with bilateral otitis media, children older than six months with severe symptoms (persistent otalgia for more than 48 hours or fever ≥102.2°F), and cases with tympanic membrane rupture and drainage. In otherwise healthy children aged six months or older with mild symptoms or uncertain diagnosis, a period of observation with close follow-up in two to three days is appropriate, provided caregivers are reliable. Antipyretics and analgesics are essential for symptom control, while antihistamines, decongestants, and steroids have not shown proven benefit.
First-line antibiotic therapy typically includes high-dose amoxicillin, with amoxicillin–clavulanate or alternative agents such as azithromycin or cefuroxime used based on allergy history, recent antibiotic use, or local resistance patterns. Parenteral antibiotics are reserved for toxic-appearing infants, immunocompromised patients, or those unable to tolerate oral therapy.
Most patients can be safely discharged with appropriate treatment and follow-up. Admission is indicated for febrile or toxic children younger than one year, immunocompromised patients, those with significant dehydration, inability to tolerate oral intake, suspected serious associated infection, unreliable caregivers, or concern for abuse. Follow-up is recommended within 10–14 days to ensure resolution, with earlier reassessment if symptoms fail to improve within 24–48 hours or worsen.
Important complications of otitis media include recurrent infections, tympanic membrane perforation, serous otitis media, hearing loss, facial nerve injury, mastoiditis, cholesteatoma, meningitis, and other intracranial infections. A key clinical pearl is that in otherwise healthy children aged six months or older with mild symptoms, observation without immediate antibiotics and close follow-up is often a safe and effective approach.
0 Comments
